亚洲胺通过调节TRIM27稳定性和激活PGC-1α/Nrf2信号来缓解慢性阻塞性肺病
Feng Zhu1, Yuxian Ji2, Qian You1
1The Fifth People's Hospital of Wuxi, Affiliated Wuxi Fifth Hospital of Jiangnan University, Wuxi City, Jiangsu Province, 214000, China.
亚西化物 (AS) 通过减少炎症和细胞损伤来缓解慢性阻塞性肺病 (COPD). 它通过涉及TRIM27和m6A-YTHDF1的机制稳定PGC-1α,从而提供一种潜在的治疗方法.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及炎症,上皮细胞-介质细胞过渡 (EMT) 和线粒体功能障碍.
- 亚洲化物 (AS) 具有与各种疾病相关的抗炎性质.
研究的目的:
- 在COPD的小鼠模型和人类支气管上皮细胞 (BEAS-2B) 中研究亚西化物 (AS) 的治疗作用和潜在机制.
主要方法:
- 通过暴露于香烟烟雾 (CS) 的小鼠和使用香烟烟雾提取物 (CSE) 的BEAS-2B细胞诱导了COPD.
- 评估AS对炎症,亡,EMT和线粒体功能的影响,使用ELISA,西部斑点,流细胞计和JC-1染色等测试.
- 通过MeRIP,Co-IP和RIP试验调查了TRIM27,m6A修饰,YTHDF1和PGC-1α的作用.
主要成果:
- 在体外和体外的COPD模型中,AS治疗剂量依赖地减少了炎症,亡,EMT和线粒体功能障碍.
- 通过通过m6A-YTHDF1-依赖途径调解的TRIM27水平的降低,AS抑制了PGC-1α的泛化和降解.
- 过度表达TRIM27抵消了AS在COPD细胞和动物模型上的保护作用.
结论:
- 亚西化物 (AS) 通过减轻关键的病理过程,显示出对COPD的显著治疗潜力.
- 该机制涉及AS通过破坏TRIM27的稳定性以m6A-YTHDF1-依赖的方式激活PGC-1α/Nrf2信号通路.
更多相关视频
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
05:03Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
Published on: October 28, 2022
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
